Sustainability & Climate

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

MediWound's burn treatment now prevents traumatic tattoos from blasts and accidents, signaling a major strategic expansion and a new era in trauma care.

A French cancer institute is the first in Europe to deploy a new radiotherapy system that promises not just better accuracy, but a more humane patient journey.

Beijing 101 blends TCM with high-tech devices for scalp care. We analyze the business strategy behind this fusion in a competitive wellness market.

A new neuroscience framework reveals why ethical leaders attract criticism, shifting the focus from leadership flaws to the observer's own brain.

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

A routine dividend from Morgan Stanley's China A-Share fund offers a deeper look into the risks and rewards of investing in China's domestic market.

A century-old brand just launched a giant, novelty product. It’s not a joke—it’s a calculated lesson in modern marketing and brand revitalization.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Amara Industries' strategic acquisition of Thomson Plastics signals a major shift, creating a tech-forward giant in North American injection molding.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A routine UK disclosure by an investment giant has pulled back the curtain on a major transatlantic auto merger and the silent influence of institutional capital.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

An Atlanta clinic's top award highlights a market shift toward minimally invasive fibroid treatment and a crucial fight for health equity in women's care.

With a new M&A-savvy CRO and Blackstone's backing, Enverus is poised for aggressive growth, aiming to dominate the AI-driven future of energy intelligence.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

A routine dividend from Imperial Petroleum reveals a powerful strategy: a debt-free balance sheet and cash-funded growth in a volatile shipping market.

A new partnership brings Febreze's brand power to the overlooked cabin air filter, aiming to transform a maintenance task into a premium consumer choice.

An Australian biotech's novel gel delivery system aims to conquer China's wellness market. But can superior tech alone build the trust needed to succeed?